ClinicalTrials.Veeva

Menu

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Sleep Apnea Syndromes
Congestive Heart Failure

Treatments

Behavioral: AirCare App

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.

Enrollment

146 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Congestive heart failure and sleep apnea

Exclusion criteria

  • Cognitive impairment

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

146 participants in 2 patient groups

Intervention
Experimental group
Description:
Study participants will receive a tablet computer with the AirCare system.
Treatment:
Behavioral: AirCare App
Control
No Intervention group
Description:
Standard care

Trial documents
1

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems